Although previous research revealed that ENO1 contributes to NSCLC progression by FAK/PI3K/AKT pathway [29], the specific mechanisms of ENO1 on regulating stem cell responses are still poorly understood. This evidence concerns the gene ENO1 and non-small cell lung carcinoma.